Figures & data
Figure 1. Design of the study. From a total population of 208 490 subjects all known patients with type 2 diabetics were surveyed and further analyses were made from a stratified randomized sample.
Table I. Baseline characteristics of 6495 patients with type 2 diabetes, by treatment category, at 18 primary care health centres in the counties of Jönköping and Östergötland, Sweden, 2003.
Figure 2. Glycaemic control measured by mean levels of HbA1c±1 SD in different treatment categories in 6495 patients with type 2 diabetes.
Table II. Characteristics in a sample of 896 patients with type 2 diabetes in the counties of Jönköping and Östergötland, Sweden, 2003. Data are shown for users and non-users of SMBG respectively by treatment category
Figure 3. Scatter diagram of HbA1c (%) and frequency of test strips consumed the week prior to telephone interview, for 533 users of SMBG with type 2 diabetes.
